Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome
Anna Richards, Elizabeth J. Kemp, M. Kathryn Liszewski et al. · Proceedings of the National Academy of Sciences · 2003
Membrane cofactor protein (MCP; CD46) is a widely expressed transmembrane complement regulator. Like factor H it inhibits complement activation by regulating C3b deposition on targets. Factor H mutations occur in 10-20% of patients with hemolytic uremic syndrome (HUS). We hypothesized that MCP mutations could predispose to HUS, and we sequenced MCP coding exons in affected individuals from 30 families. MCP mutations were detected in affected individuals of three families: a deletion of two amino acids (D237/S238) in family 1 (heterozygous) and a substitution, S206P, in families 2 (heterozygous) and 3 (homozygous). We evaluated protein expression and function in peripheral blood mononuclear cells from these individuals. An individual with the D237/S238 deletion had reduced MCP levels and approximately 50% C3b binding compared with normal controls. Individuals with the S206P change expressed normal quantities of protein, but demonstrated approximately 50% reduction in C3b binding in heterozygotes and complete lack of C3b binding in homozygotes. MCP expression and function was evaluated in transfectants reproducing these mutations. The deletion mutant was retained intracellularly. S206P protein was expressed on the cell surface but had a reduced ability to prevent complement activation, consistent with its reduced C3b binding and cofactor activity. This study presents further evidence that complement dysregulation predisposes to development of thrombotic microangiopathy and that screening patients for such defects could provide informed treatment strategies.
Cited by 405 works. doi:10.1073/pnas.2135497100
Authors
- Anna Richards
- Elizabeth J. Kemp
- M. Kathryn Liszewski
- Judith A. Goodship
- Anne Katrin Lampe
- Ronny Decorte
- Hamza Müslümanoğlu
- Salìh Kavukçu
- Guido Filler
- Yves Pirson
- Leana S. Wen
- John P. Atkinson
- Timothy H.J. Goodship
References
- Thrombotic Microangiopathies
- Genetic studies into inherited and sporadic hemolytic uremic syndrome
- Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell Recognition
- The Molecular Basis of Familial Hemolytic Uremic Syndrome
- Clustering of Missense Mutations in the C-Terminal Region of Factor H in Atypical Hemolytic Uremic Syndrome
- Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome
- Control of the Complement System
- Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.
- Structural and Functional Characterization of Factor H Mutations Associated with Atypical Hemolytic Uremic Syndrome
- Complement Factor H Gene Mutation Associated with Autosomal Recessive Atypical Hemolytic Uremic Syndrome